Cited by 107Nanoparticle-Based Drug DeliveryAdvancements in Transdermal Drug DeliveryInhalation and Respiratory Drug Delivery

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Enhanced rifampicin delivery to alveolar macrophages by solid lipid nanoparticles

Chuan, Junlan, Li, Yanzhen, Yang, Likai, Sun, Xun, Zhang, Qiang, Gong, Tao, Zhang, Zhirong·2013·Journal of Nanoparticle Research

DOI 10.1007/s11051-013-1634-1

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1007/s11051-013-1634-1

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Regulated portals of entry into the cell
Conner, S. D., & Schmid, S. L. (2003) · Nature · doi:10.1038/nature01451 · Cited by 3,958
Arzneimittelforschung
Bethke, T. D. (2012) · Der Pneumologe · doi:10.1007/s10405-012-0601-3 · Cited by 3,286
Mechanisms of phagocytosis in macrophages
Aderem, A., & Underhill, D. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.593 · Cited by 2,854
Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles
He, C., Hu, Y., Yin, L., Tang, C., & Yin, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.065 · Cited by 2,607
Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase
McKinney, J. D., zu Bentrup, K. H., Muñoz‐Elías, E. J., Miczák, A., Chen, B., Chan, W.-T., Swenson, D. L., Sacchettini, J. C., Jacobs, W. R., & Russell, D. G. (2000) · Nature · doi:10.1038/35021074 · Cited by 1,361
RESPONSE OF CULTURED MACROPHAGES TO MYCOBACTERIUM TUBERCULOSIS , WITH OBSERVATIONS ON FUSION OF LYSOSOMES WITH PHAGOSOMES
Armstrong, J. A., & Hart, P. D. (1971) · The Journal of Experimental Medicine · doi:10.1084/jem.134.3.713 · Cited by 991
A Coat Protein on Phagosomes Involved in the Intracellular Survival of Mycobacteria
Ferrari, G., Langen, H., Naito, M., & Pieters, J. (1999) · Cell · doi:10.1016/s0092-8674(00)80754-0 · Cited by 586
CELL BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS PHAGOSOME
Vergne, I., Chua, J., Singh, S., & Deretic, V. P. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.114015 · Cited by 440
Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis
Pandey, R., & Khuller, G. K. (2005) · Tuberculosis · doi:10.1016/j.tube.2004.11.003 · Cited by 318
Oral solid lipid nanoparticle-based antitubercular chemotherapy
Pandey, R., Sharma, S., & Khuller, G. K. (2005) · Tuberculosis · doi:10.1016/j.tube.2005.08.009 · Cited by 271

Show all 37 references

Sorted by citations

Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645
Nanotechnology approaches for global infectious diseases
Kirtane, A. R., Verma, M., Karandikar, P., Furin, J., Langer, R., & Traverso, G. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00866-8 · Cited by 520
Nanoparticle-Mediated Pulmonary Drug Delivery: A Review
Paranjpe, M., & Müller-Goymann, C. C. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15045852 · Cited by 467
Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers – A systematic review of in vitro data
Doktorovová, S., Souto, E. B., & Silva, A. M. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.02.005 · Cited by 419
Physicochemical properties affecting the fate of nanoparticles in pulmonary drug delivery
Liu, Q., Guan, J., Lu, Q., Zhang, X., & Mao, S. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.09.023 · Cited by 239
Solid lipid nanocarriers in drug delivery: characterization and design
Mu, H., & Holm, R. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1504018 · Cited by 145
The formulation of nanomedicines for treating tuberculosis
Costa, A., Pinheiro, M., Magalhães, J., Ribeiro, R., Seabra, V., Reis, S., & Sarmento, B. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.012 · Cited by 123
RETRACTED: The emergence of metal oxide nanoparticles (NPs) as a phytomedicine: A two-facet role in plant growth, nano-toxicity and anti-phyto-microbial activity
Bhattacharjee, R., Kumar, L., Mukerjee, N., Anand, U., Dhasmana, A., Preetam, S., Bhaumik, S., Sihi, S., Pal, S., Khare, T. R., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113658 · Cited by 115
Retracted
Highly efficient removal of antibiotic rifampicin from aqueous solution using green synthesis of recyclable nano-Fe3O4
Cai, W., Weng, X., & Chen, Z. (2019) · Environmental Pollution · doi:10.1016/j.envpol.2019.01.108 · Cited by 108
Critical physicochemical and biological attributes of nanoemulsions for pulmonary delivery of rifampicin by nebulization technique in tuberculosis treatment
Shah, K. U., Chan, L. W., & Wong, T. W. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1384298 · Cited by 92
Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis
Maretti, E., Rossi, T., Bondi, M., Croce, M. A., Hanuskovà, M., Leo, E., Sacchetti, F., & Iannuccelli, V. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.12.034 · Cited by 85
Rifampicin Loaded Mannosylated Cationic Nanostructured Lipid Carriers for Alveolar Macrophage-specific Delivery
Song, X. C., Lin, Q., Guo, L. H., Fu, Y. S., Han, J., Ke, H., Sun, X., Gong, T., & Zhang, Z. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1572-3 · Cited by 82
Self-citation
Unleashing the Quadratic Nonlinear Optical Responses of Graphene by Confining White-Graphene (h-BN) Sections in Its Framework
Karamanis, P., Otero, N., & Pouchan, C. (2014) · Journal of the American Chemical Society · doi:10.1021/ja502631w · Cited by 81
Nebulized solid lipid nanoparticles for the potential treatment of pulmonary hypertension via targeted delivery of phosphodiesterase-5-inhibitor
Makled, S., Nafee, N. A., & Boraie, N. A. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.12.026 · Cited by 82
Visible Light Catalysis-Assisted Assembly of Nih-QD Hollow Nanospheres in Situ via Hydrogen Bubbles
Li, Z., Fan, X., Li, X., Li, J., Ye, C., Wang, J.-J., Yu, S., Li, C., Gao, Y., Meng, Q., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5047236 · Cited by 78
Preparation and characterization of isoniazid-loaded crude soybean lecithin liposomes
Nkanga, C. I., Krause, R. W. M., Siwe‐Noundou, X., & Walker, R. B. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.04.074 · Cited by 73
Graphene metal nanocomposites — Recent progress in electrochemical biosensing applications
Khalil, I., Rahmati, S., Julkapli, N. M., & Yehye, W. A. (2017) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2017.11.001 · Cited by 69
How can nanoparticles contribute to antituberculosis therapy?
Costa-Gouveia, J., Aínsa, J. A., Brodin, P. M., & Lucía, A. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.01.011 · Cited by 68
Towards understanding the antibacterial activity of Ag nanoparticles: electron microscopy in the analysis of the materials-biology interface in the lung
Heras, I. L., Theodorou, I. G., Leo, B. F., Ryan, M. P., & Porter, A. E. (2015) · Environmental Science Nano · doi:10.1039/c5en00051c · Cited by 69
Design and statistical modeling of mannose-decorated dapsone-containing nanoparticles as a strategy of targeting intestinal M-cells
Pinheiro, M., Couto, A., Chaves, L. L., Ferreira, D., Sarmento, B. F. C. C., & Reis, S. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s104908 · Cited by 65
Nanostructured lipid carriers versus solid lipid nanoparticles for the potential treatment of pulmonary hypertension via nebulization
Nafee, N. A., Makled, S., & Boraie, N. A. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.10.003 · Cited by 62
Rifampicin-Carbohydrate Spray-Dried Nanocomposite: A Futuristic Multiparticulate Platform For Pulmonary Delivery
Mehanna, M. M., Mohyeldin, S. M., & Elgindy, N. A. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s211182 · Cited by 53
Surfactant-modified flowerlike layered double hydroxide-coated magnetic nanoparticles for preconcentration of phthalate esters from environmental water samples
Zhao, X., Liu, S., Wang, P., Tang, Z., Niu, H., Cai, Y., Wu, F., Wang, H., Meng, W., & Giesy, J. P. (2015) · Journal of Chromatography A · doi:10.1016/j.chroma.2015.07.105 · Cited by 51
Comparative Pulmonary Toxicity of Two Ceria Nanoparticles with the Same Primary Size
Peng, L., He, X. B., Zhang, P., Zhang, J., Li, Y., Zhang, J., Ma, Y., Ding, Y., Wu, Z., Chai, Z., et al. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15046072 · Cited by 51
Self-citation
Role of Novel Drug Delivery Vehicles in Nanobiomedicine
Tyagi, R. K. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.77468 · Cited by 51
Highly Efficient Adsorption of Heavy Metals onto Novel Magnetic Porous Composites Modified with Amino Groups
Ren, C., Ding, X., Li, W., Wu, H., & Yang, H. Y. (2017) · Journal of Chemical & Engineering Data · doi:10.1021/acs.jced.7b00198 · Cited by 47
Recyclable superparamagnetic adsorbent based on mesoporous carbon for sequestration of radioactive Cesium
Husnain, S. M., Um, W., Chang, Y., & Chang, Y. (2016) · Chemical Engineering Journal · doi:10.1016/j.cej.2016.09.116 · Cited by 44
Is Nanotechnology Helping in the Fight Against COVID-19?
Cardoso, V. M. D. O., Moreira, B. J., Comparetti, E. J., Sampaio, I., Ferreira, L. M. B., Lins, P. M. P., & Zucolotto, V. (2020) · Frontiers in Nanotechnology · doi:10.3389/fnano.2020.588915 · Cited by 42
Nanosized Drug Delivery Systems to Fight Tuberculosis
Bourguignon, T., Godinez-Leon, J. A., & Gref, R. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020393 · Cited by 42
Nanotechnology Integration for SARS-CoV-2 Diagnosis and Treatment: An Approach to Preventing Pandemic
Asdaq, S. M. B., Ikbal, A. M. A., Sahu, R. K., Bhattacharjee, B., Paul, T., Deka, B., Fattepur, S., Widyowati, R., Vijaya, J., Mohaini, M. A., et al. (2021) · Nanomaterials · doi:10.3390/nano11071841 · Cited by 42
Nanocarriers for tuberculosis therapy: Design of safe and effective drug delivery strategies to overcome the therapeutic challenges
Sarkar, K., Kumar, M., Jha, A., Bharti, K., Das, M., & Mishra, B. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102850 · Cited by 36
In Vitro Activity of Copper(II) Complexes, Loaded or Unloaded into a Nanostructured Lipid System, against Mycobacterium tuberculosis
da Silva, P. B., de Souza, P. C., Calixto, G. M. F., Lopes, É. D. O., Frem, R. C. G., Netto, A. V. G., MAURO, A. E., Pavan, F. R., & Chorilli, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050745 · Cited by 35
Development and In Vitro Release of Isoniazid and Rifampicin-Loaded Bovine Serum Albumin Nanoparticles
Ge, Z., Ma, R., Xu, G., Chen, Z., Zhang, D., Wang, Q., Hei, L., & Wei, M. (2018) · Medical Science Monitor · doi:10.12659/msm.905581 · Cited by 35
Nanoparticle-mediated macrophage targeting—a new inhalation therapy tackling tuberculosis
Makled, S., Boraie, N. A., & Nafee, N. A. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00815-3 · Cited by 35
Preparation and evaluation of gemcitabin and cisplatin-entrapped Folate-PEGylated liposomes as targeting co-drug delivery system in cancer therapy
Goli, P. P., Torbati, M. B., Parivar, K., Akbarzadeh, A., & Yousefi, M. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102756 · Cited by 30
Emerging strategies in nanotechnology to treat respiratory tract infections: realizing current trends for future clinical perspectives
Chen, M., Shou, Z., Jin, X., & Chen, Y. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2089294 · Cited by 34
Nanomedicines towards targeting intracellular Mtb for the treatment of tuberculosis
Donnellan, S., & Giardiello, M. (2019) · Journal of Interdisciplinary Nanomedicine · doi:10.1002/jin2.61 · Cited by 31
pH-Dependent release of isoniazid from isonicotinic acid (4-hydroxy-benzylidene)-hydrazide loaded liposomes
Nkanga, C. I., Walker, R. B., & Krause, R. W. M. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.03.016 · Cited by 29
Active pulmonary targeting against tuberculosis (TB) via triple-encapsulation of Q203, bedaquiline and superparamagnetic iron oxides (SPIOs) in nanoparticle aggregates
Poh, W., Rahman, N. B. A., Ostrovski, Y., Sznitman, J., Pethe, K., & Loo, S. C. J. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1676841 · Cited by 29
Potential of nanotechnology as a delivery platform against tuberculosis: Current research review
Choudhary, S., & Devi, V. K. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.035 · Cited by 28
In vitro controlled release of Rifampicin through liquid-crystalline folate nanoparticles
Parmar, R., Misra, R. D., & Mohanty, S. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.03.051 · Cited by 28
Synthesis, characterization and photoluminescence properties of tetra(aminophenyl) porphyrin covalently linked to multi-walled carbon nanotubes
Prabhavathi, G., Arjun, M. S., & Yamuna, R. (2017) · Journal of Chemical Sciences · doi:10.1007/s12039-017-1295-1 · Cited by 28
Porous PLGA microparticles formed by “one-step” emulsification for pulmonary drug delivery: The surface morphology and the aerodynamic properties
Nishimura, S., Takami, T., & Murakami, Y. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.08.004 · Cited by 28
Conjugation of isoniazid to a zinc phthalocyanine via hydrazone linkage for pH-dependent liposomal controlled release
Nkanga, C. I., & Krause, R. W. M. (2018) · Applied Nanoscience · doi:10.1007/s13204-018-0776-y · Cited by 28
Evaluating of novel Mn–Mg–Co ferrite nanoparticles for biomedical applications: From synthesis to biological activities
Bentarhlia, N., Elansary, M., Belaiche, M., Mouhib, Y., Lemine, O. M., Zaher, H., Oubihi, A., Kartah, B. E., & Monfalouti, H. E. (2023) · Ceramics International · doi:10.1016/j.ceramint.2023.10.017 · Cited by 25
Facile synthesis of novel flowerlike magnetic mesoporous carbon for efficient chlorophenols removal
Liu, S., Li, S., Niu, H., Zeng, T., Cai, Y., Shi, C., Zhou, B., Wu, F., & Zhao, X. (2014) · Microporous and Mesoporous Materials · doi:10.1016/j.micromeso.2014.08.046 · Cited by 25
Development of respirable rifampicin loaded bovine serum albumin formulation for the treatment of pulmonary tuberculosis
Joshi, M., & Prabhakar, B. R. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.102197 · Cited by 24
Insights into innovative therapeutics for drug-resistant tuberculosis: Host-directed therapy and autophagy inducing modified nanoparticles
Khoza, L. J., Kumar, P., Dube, A., Demana, P. H., & Choonara, Y. E. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121893 · Cited by 24
Nanotechnology and COVID-19 Convergence: Toward New Planetary Health Interventions Against the Pandemic
Sahoo, P., Dey, J., Mahapatra, S. R., Ghosh, A., Jaiswal, A., Padhi, S., Prabhuswamimath, S. C., Misra, N., & Suar, M. (2022) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2022.0072 · Cited by 24
Graphene oxide functionalized by poly(ionic liquid)s for carbon dioxide capture
Huang, L., Jin, Y., Sun, L. J., Chen, F., Fan, P., Zhong, M., & Yang, J. (2016) · Journal of Applied Polymer Science · doi:10.1002/app.44592 · Cited by 23
Fabrication and Characterization of Surface Engineered Rifampicin Loaded Lipid Nanoparticulate Systems for the Potential Treatment of Tuberculosis: An In Vitro and In Vivo Evaluation
Chokshi, N. V., Rawal, S. U., Solanki, D., Gajjar, S., Bora, V. R., Patel, B. M., & Patel, M. M. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.02.018 · Cited by 24
Freeze-dried vs spray-dried nanoplex DPIs based on chitosan and its derivatives conjugated with hyaluronic acid for tuberculosis: In vitro aerodynamic and in silico deposition profiles
Mukhtar, M., Szakonyi, Z., Farkas, Á., Burián, K., Kókai, D., & Ambrus, R. (2021) · European Polymer Journal · doi:10.1016/j.eurpolymj.2021.110775 · Cited by 22
Dual antitubercular drug loaded liposomes for macrophage targeting: development, characterisation, ex vivo and in vivo assessment
Shrivastava, P., Gautam, L., Sharma, R. K., Dube, D., Vyas, S., & Vyas, S. P. (2020) · Journal of Microencapsulation · doi:10.1080/02652048.2020.1857861 · Cited by 22
Micro-nanoemulsion and nanoparticle-assisted drug delivery against drug-resistant tuberculosis: recent developments
Suman, S. K., Chandrasekaran, N., & Doss, C. G. P. (2023) · Clinical Microbiology Reviews · doi:10.1128/cmr.00088-23 · Cited by 21
The Role of Langmuir Monolayers To Understand Biological Events
Caseli, L., Nobre, T. M., Ramos, A. P., Monteiro, D. S., & Zaniquelli, M. E. D. (2015) · ACS symposium series · doi:10.1021/bk-2015-1215.ch004 · Cited by 20
Cure of tuberculosis using nanotechnology: An overview
Kerry, R. G., Gouda, S., Sil, B., Das, G., Shin, H., Ghodake, G. S., & Patra, J. K. (2018) · The Journal of Microbiology · doi:10.1007/s12275-018-7414-y · Cited by 20
Photobleaching-resistant ternary quantum dots embedded in a polymer-coated silica matrix
Guguła, K., Szydło, A., Stegemann, L., Strassert, C. A., & Bredol, M. (2016) · Journal of Materials Chemistry C · doi:10.1039/c6tc00943c · Cited by 20
Automated determination of Rifamycins making use of MPA–CdTe quantum dots
Jiménez-López, J., Molina‐García, L., Rodrigues, S. S. M., Santos, J. L. M., Ortega-Barrales, P., & Ruiz-Medina, A. (2016) · Journal of Luminescence · doi:10.1016/j.jlumin.2016.02.036 · Cited by 19
Lipid nanoparticles with improved biopharmaceutical attributes for tuberculosis treatment
Gordillo-Galeano, A., Ospina-Giraldo, L. F., & Mora‐Huertas, C. E. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120321 · Cited by 19
Synthesis, characterization and photoluminescence properties of graphene oxide functionalized with azo molecules
Devi, R. A., Prabhavathi, G., Yamuna, R., Ramakrishnan, S., & Kothurkar, N. K. (2014) · Journal of Chemical Sciences · doi:10.1007/s12039-013-0536-1 · Cited by 17
Use of nanotechnology in combating coronavirus
Gharpure, S., & Ankamwar, B. G. (2021) · 3 Biotech · doi:10.1007/s13205-021-02905-6 · Cited by 17
Review of inhalable nanoparticles for the pulmonary delivery of anti-tuberculosis drugs
Ramachandran, S., Prakash, P., Mohtar, N., Kumar, K. S., & Parumasivam, T. (2023) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2023.2279691 · Cited by 16
The Magnetic, Mechanical, Thermal Properties and Uv Resistance of CoFe2O4/SiO2-Coated Film on Wood
Gan, W., Gao, L., Liu, Y., Zhan, X., & Li, J. (2015) · Journal of Wood Chemistry and Technology · doi:10.1080/02773813.2015.1074247 · Cited by 15
Solid Lipid Nanoparticles in Tuberculosis
Rana, D., Salave, S., Patel, R. P., Khunt, D., Misra, M., Prajapati, B. G., Patel, G. K., & Patel, J. K. (2023) · Springer eBooks · doi:10.1007/978-3-031-14100-3_6 · Cited by 14
Nanoformulations and Clinical Trial Candidates as Probably Effective and Safe Therapy for Tuberculosis
Laghari, M., Darwis, Y., Memon, A. H., Khan, A. A., Abdulbaqi, I. M., & Assi, R. A. (2016) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v15i1.28 · Cited by 14
Co-encapsulation of Rifampicin and Isoniazid in Crude Soybean Lecithin Liposomes
Nkanga, C. I., Siwe‐Noundou, X., Walker, R. B., & Krause, R. W. M. (2019) · South African Journal of Chemistry · doi:10.17159/0379-4350/2019/v72a11 · Cited by 13
Enhanced adsorptive removal of rifampicin and tigecycline from single system using nano-ceria decorated biochar of mango seed kernel
El‐Azazy, M., El‐Shafie, A. S., Al-Mulla, R., Hassan, S. S., & Nimir, H. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15802 · Cited by 12
Rifampicin adsorbed onto magnetite nanoparticle: SERS study and insight on the molecular arrangement and light effect
Ferreira, Q. S., da Silva, S. W., Santos, C. M. B., Ribeiro, G., Guilherme, L. R., & Morais, P. C. (2015) · Journal of Raman Spectroscopy · doi:10.1002/jrs.4718 · Cited by 11
Ultrafast all-optical universal logic gates with graphene and graphene-oxide metal porphyrin composites
Yadav, C., & Roy, S. (2014) · Journal of Computational Electronics · doi:10.1007/s10825-014-0633-5 · Cited by 11
The Developmental Toxicity of Complex Silica-Embedded Nickel Nanoparticles Is Determined by Their Physicochemical Properties
Mahoney, S., Najera, M., Bai, Q., Burton, E. A., & Veser, G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152010 · Cited by 10
Nano-engineered solutions for extensively drug-resistant tuberculosis (XDR-TB): A novel nanomedicine
Singh, D., Krishna, V. S., Kumari, N., Banerjee, A., & Kapoor, P. (2024) · Nano-Structures & Nano-Objects · doi:10.1016/j.nanoso.2024.101390 · Cited by 8
Solid Lipid Based Nano-particulate Formulations in Drug Targeting
Mohanta, B. C., Dinda, S. C., Palei, N. N., & Deb, J. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.88268 · Cited by 8
Nanotechnology as a potential tool against drug- and multidrug-resistant tuberculosis
Pérez-Martínez, D. E., & Zenteno‐Cuevas, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819811-7.00003-5 · Cited by 8
Meta-Analysis of Drug Delivery Approaches for Treating Intracellular Infections
Shin, S., Kwon, S., & Yeo, Y. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03188-z · Cited by 8
Nanostructured lipid carrier-based drug delivery systems for tuberculosis treatment
Carneiro, S. P., & dos Santos, O. D. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819811-7.00012-6 · Cited by 7
Surface-modified CuO nanoparticles for photocatalysis and highly efficient energy storage devices
Pandith, A., Jayaprakash, G. K., & ALOthman, Z. A. (2023) · Environmental Science and Pollution Research · doi:10.1007/s11356-023-25131-4 · Cited by 7
A novel acemannan-chitosan modified lipid nanoparticles as intracellular delivery vehicles of antibiotic
Suciati, T. A., Rachmawati, P., Soraya, E., Mahardhika, A. B., Satrialdi, Hartarti, R., & Anggadiredja, K. (2018) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2018.81201 · Cited by 7
Applications of Nanotechnology in Phytoremediation
Sharma, A., Mittal, V., Grover, R., Sharma, D., Gupta, V., & Kumar, K. (2024) · Springer eBooks · doi:10.1007/978-3-031-60761-5_14 · Cited by 6
Design, fabrication, and in vitro-in vivo evaluation of surface-engineered pyrazinamide-loaded lipid nanoparticles for tuberculosis therapy
Chokshi, N. V., Vinchhi, P., Chauhan, S., Bora, V. R., Patel, B. M., & Patel, M. M. (2025) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2025.2492136 · Cited by 6
Approaches for designing and delivering solid lipid nanoparticles of distinct antitubercular drugs
Vasam, M., & Goulikar, R. K. (2022) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2022.2144791 · Cited by 5
Lipid nanoparticles as carriers for delivery of anti-inflammatory drugs
Kovačević, A. B., Silva, S. M. C., & Doktorovová, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-40016-9.00005-1 · Cited by 6
Nebulized, macrophage-targeted, Linezolid-loaded lipid carriers for intracellular treatment of tubercular infections – In vitro/in vivo study
Makled, S., Nafee, N. A., Okasha, H. A. S., & Boraie, N. A. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106202 · Cited by 4
Precision nanomedicine against pulmonary tuberculosis: the role of lipid-based drug delivery systems
He, N., Dong, K., Lee, W., & Bach, H. (2026) · Nanomedicine · doi:10.1080/17435889.2026.2624741 · Cited by 4
Synthesis and application of streptavidin functionalized organosilica microparticles
Hou, C., Zhang, L., Wang, Y., & Wang, Z. (2014) · Journal of Applied Polymer Science · doi:10.1002/app.41560 · Cited by 4
Formulation, characterization and evaluation of inhalable effervescent dry powder of Rifampicin nanoparticles
Rai, P. Y., Sansare, V. A., Warrier, D. U., & Shinde, U. A. (2022) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2022.03.007 · Cited by 4
Host-directed strategies using lipid nanoparticles to reduce mycobacteria survival
Pereira, L. P., Diogo, J., Mateus, R., Pimentel, M., & Videira, M. (2015) · Journal of Nanoparticle Research · doi:10.1007/s11051-015-2892-x · Cited by 4
The synthesis, application and therapeutic perspectives of medicinal plants-based solid lipid nanoparticles: a comprehensive review
Mottaqi, M., Langarizadeh, M. A., Molaali, N., Rezaei, M., Ameri, A., & Forootanfar, H. (2024) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-024-00787-6 · Cited by 3
Nanomedicines in Tuberculosis: Diagnosis, Therapy and Nanodrug Delivery
Dakkah, A. N., Bataineh, Y. A., Al-Jaidi, B. A., Bayan, M. F., & Nimer, N. A. (2020) · Engineering materials · doi:10.1007/978-3-030-36260-7_13 · Cited by 3
Fabrication and in vitro–in vivo evaluation of ligand appended isoniazid loaded nanoparticulate systems for the treatment of tuberculosis
Chokshi, N. V., Bora, V. R., Rawal, S. U., Vinchhi, P., Gajjar, S., Patel, B. M., & Patel, M. M. (2024) · Journal of Dispersion Science and Technology · doi:10.1080/01932691.2024.2348511 · Cited by 4
Nanopartículas como transportadores de fármacos: una herramienta prometedora contra la tuberculosis
Luna‐Herrera, J., Pérez-Martínez, D. E., Barradas-Hernández, V. M., & Zenteno‐Cuevas, R. (2021) · Revista Peruana de Medicina Experimental y Salud Pública · doi:10.17843/rpmesp.2021.381.6156 · Cited by 3
Monitoring of an Antituberculosis Drug Degradation under UV Radiation
Kais, H., Mezenner, N. Y., Bensaadi, Z., & Hamadi, A. (2022) · Russian Journal of Physical Chemistry A · doi:10.1134/s0036024422100107 · Cited by 2
Evaluation of Lung Toxicity of Biodegradable Nanoparticles
Grabowski, N., Hillaireau, H., Vergnaud, J., & Fattal, E. (2014) · Advances in delivery science and technology · doi:10.1007/978-3-319-11355-5_22 · Cited by 2
Macrophage-Targeted Chemotherapy for Tuberculosis
Shrivastava, P., Gautam, L., Vyas, S., & Vyas, S. P. (2022) · Springer eBooks · doi:10.1007/978-3-030-84164-5_17 · Cited by 2
Pharmacoengineering of Lipid Nanoarchitectonics in Modulating Particle Uptake by Lung Macrophages
Thalla, M., & Banerjee, S. (2021) · Wiley eBooks · doi:10.1002/9783527832095.ch12 · Cited by 2
Exploration of Biocompatibility and Toxicity of Nanomaterials in Diagnosis and Treatment of Infectious Diseases
Puvvada, N., Chandu, B., & Panigrahi, P. K. (2025) · Wiley eBooks · doi:10.1002/9781394200559.ch11 · Cited by 2
Surface-Engineered Ethambutol-Loaded Nanoparticles: Design, Fabrication, and In Vitro–In Vivo Evaluation for Tuberculosis Therapy
Chokshi, N. V., Naik, J., Bora, V. R., Patel, B. M., & Patel, M. M. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c01018 · Cited by 1
Perspective on Solid Lipid Nanoparticles as Drug Delivery System for Infectious Diseases
Ayare, P., Bakre, A., & Hirlekar, R. S. (2024) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.1293 · Cited by 1
Nanotherapeutics in tuberculosis: Pulmonary and extrapulmonary applications
Bisht, S., Jaiswal, V., & Singh, M. F. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-28836-4.00011-1 · Cited by 1
Estudo SERS de carreadores nanoparticulados de fármacos baseados em nanopartículas magnéticas e poliméricas
Ferreira, Q. S. (2015) · doi:10.26512/2015.05.t.18655
Nanomedicines for the treatment of tuberculosis
Donnellan, S. (2016)

Authors: Chuan, J., Li, Y., Yang, L., Sun, X., Zhang, Q., Gong, T., & Zhang, Z.
Affiliations: Sichuan University (CN)
Tianjin Institute of Pharmaceutical Research (China) (CN)
Peking University (CN)
Corresponding author: Gong, Tao
Zhang, Zhirong
ORCID: Chuan, Junlan
Li, Yanzhen
Yang, Likai
Sun, Xun
Gong, Tao
Zhang, Zhirong
Venue: Journal of Nanoparticle Research
Publisher: Springer Science and Business Media LLC
Published: 2013-04-11
Volume: 15
Issue: 5
ISSN: 1388-0764 (ISSN-L)
1572-896X
DOI: 10.1007/s11051-013-1634-1
OpenAlex: W2016812928
Cited by: 107
References: 37
Citations by year: 2026: 3 · 2025: 4 · 2024: 6 · 2023: 7 · 2022: 9 · 2021: 10 · 2020: 9 · 2019: 11 · 2018: 8 · 2017: 7 · 2016: 11 · 2015: 10 · 2014: 11 · 2013: 1
FWCI: 4.20
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Journal of Nanoparticle Research (publishedVersion)
Funders: International Society of Travel Medicine
National Key Research and Development Program of China
Topics: Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
Keywords: rifampicin, solid lipid nanoparticles, alveolar macrophages, tuberculosis, targeted drug delivery, alveolar type II cells, nanoparticle uptake, pulmonary administration, lipid film hydration, cytotoxicity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Enhanced rifampicin delivery to alveolar macrophages by solid lipid nanoparticles

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks